Galapagos NV
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
30 may 2024 - 22:13
Statutory name
Galapagos NV
Title
Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future so
Date last update: 03 September 2024